ICYMI Webinar Recap: Weight Loss and the Cardiometabolic Crisis - Lark Health Blog

What you'll learn

• The GLP-1 Sustainability Gap: Demand for GLP-1s has increased over 300% since 2020. Unlike "curable" specialty drugs, these are often lifetime medications, creating long-term cost challenges. - Behavioral Integration is Non-Negotiable: Clinical outcomes improve when medication is paired with real-time biometric tracking and lifestyle coaching. - Transparency as a Cost Lever: Shifting from traditional PBMs to transparent, pass-through models can reduce aggregate costs by 20–30%. - Data Ownership: Benefit leaders must reclaim ownership of their data to streamline prior authorizations and evaluate vendor outcomes effectively.

Topics covered